Shermaine Tilley
Independent DirectorDr. Shermaine Tilley, Ph.D., MBA, serves as a Managing Partner at CTI Life Sciences, since 2006. She served as Director at Ability Pharmaceuticals, S.L. since August 2024. Dr. Tilley served as a Partner at CTI Life Sciences. Dr. Tilley has been a Board Member of Phenomic AI, Toronto Innovation Acceleration Partners, Phemi. She served as a Vice President of Investment Analysis and Research and Director of Biotechnology and Pharmaceutical Research at DRI Capital Inc. Prior to joining CTI Life Sciences, she served as a Senior Vice President at DRI Capital Inc. and played a leading role in closing 12 transactions. She was primarily responsible for financial modeling and due diligence on investment opportunities. She ran and managed a research laboratory, holding faculty positions at the NYU School of Medicine and Public Health Research Institute (PHRI) and on the PHRI Board of Directors. Concomitantly with her tenure at NYU School of Medicine and PHRI. She consulted for the National Institutes of Health Small Business Innovation Research (SBIR) program in immunology and infectious disease for 10 years. She is Independent Director of IMV Inc. since June 2024 and had been its Director since June 8, 2016, until March 28, 2023. She serves on the Board of Directors at CellAegis Devices. She serves as a Director of Chlorion Pharma, Inc. She was a Director of Xagenic Inc. She was a Director of PHEMI Systems Corporation since July 2015. She serves as an Observer on the Boards of Chlorion Pharma and NeurAxon. Since 2002, she has been a Member of the Rotman (U. Toronto School of Management) Advancement Board. She serves on BIOTECanada Emerging Companies Advisory Board. She served as an Observer on the Enobia Pharma Board of Directors. She served as a Director of Zymeworks Inc. since June 2009 until May 3, 2017. Dr. Tilley holds a Ph.D. in Biochemistry from the Johns Hopkins University School of Medicine and an M.B.A. from the University of Toronto and is a CFA Charter holder, of Toronto.
Positions
- Company NameIMV Inc.Stock CodeIMVIFPositionIndependent Director
